Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer

Completed

Conditions studied: Pancreatic Cancer

In brief

The goal of this clinical research study is to learn about symptoms related to chemotherapy and the disease, in patients with advanced pancreatic cancer. Researchers will study the possible reason for these symptoms by drawing blood samples and comparing the test results to the symptoms you experience. The study will also use a special telephone system for measuring the symptoms of participants during and after therapy. Your level of physical activity will also be studied using a pedometer and study diary.

Key facts

Study ID

NCT00805688

Run by

M.D. Anderson Cancer Center

People needed

100

Starts

2008-11-12

Expected to finish

2018-02-27

Last updated by the study team

2018-03-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have histologically or cytologically confirmed cancer of the pancreas.
• Patients must have inoperable locally advanced or metastatic disease.
• Patients could be on treatment, or being planned for chemotherapy treatment.
• Age 18 years of age or older
• ECOG performance status 0-3
• Ability to give consent in either English or Spanish

You may not qualify if…

• Any condition (including unwillingness) that would impair the patient's ability to utilize the IVR system
• Any recent surgical procedures (within 14 days, excluding biopsy, port-a-cath or picc line placement)

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.